Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results.
IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...
iStock’s ever-growing Signature collection features millions of authentic images—including these awe-inspiring Tattoo illustrations—that you won’t find on any other stock site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback